The U.S. Food and Drug Administration provided its safety review timeline update in response to a court-ordered deadline in a lawsuit brought by the state of Louisiana, which alleges mail-order mifepristone undermines its state abortion ban

From the articleFDA says its review of abortion pill will continue into next yearAlso in FDA says it will complete safety review of abortion pill in March, FDA's abortion pill safety review continuing into next year angers abortion rights opponents, FDA says its review of abortion pill will continue into next year, DA Says It Won't Act On Abortion Drugs Till March, 2 Years After Pledging To Review Safety Concerns, FDA says its safety review of abortion pill will continue into next year | CNN